创业慧康 reported revenue of ¥0.45B for the period ended 2026-06-30, -21.2% year on year. Net income was ¥-0.19B, a -42.7% net margin on a 34.7% gross margin. The largest revenue line is 技术服务 at 46% of the total. Free cash flow for the period was ¥-0.27B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.45B | -21.2% |
| Gross profit | ¥0.16B | — |
| Operating income | ¥-0.20B | — |
| Net income | ¥-0.19B | — |
| Gross margin | 34.7% | Net margin -42.7% |
| Revenue Q/Q | +30.4% | — |
| Segment | Revenue | Share |
|---|---|---|
| 技术服务 | ¥0.21B | 45.6% |
| 软件销售 | ¥0.19B | 41.4% |
| 系统集成 | ¥0.05B | 11.0% |
| 其他 | ¥0.01B | 1.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.30B | 65.3% |
| R&D | ¥0.15B | 33.4% |
| SG&A | ¥0.15B | 32.9% |
| Tax & other | ¥-0.00B | -0.6% |
| Item | Amount |
|---|---|
| Total assets | ¥5.00B |
| Total liabilities | ¥1.12B |
| Shareholders' equity | ¥3.88B |
| Equity / assets | 77.6% |
| Operating cash flow | ¥-0.26B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥-0.27B |
| Cash conversion (OCF / net income) | 233% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
山河药辅 ・ 三鑫医疗 ・ 深信服 ・ 航天智装 ・ 赛微电子 ・ 赢合科技 ・ 全志科技 ・ 汤姆猫 ・ ST惠伦 ・ 田中精机 ・ ST华铭 ・ 迈克生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies